Royalty Pharma
RPRX
#1039
Rank
HK$145.20 B
Marketcap
HK$251.90
Share price
-0.31%
Change (1 day)
7.27%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2023 (TTM): HK$4.35

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is HK$4.28. In 2022 the company made an earnings per share (EPS) of HK$0.78 a decrease over its 2021 EPS that were of HK$11.68.

EPS history for Royalty Pharma from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$4.35458.77%
2022HK$0.78-93.33%
2021HK$11.68-1.33%
2020HK$11.83-77.07%
2019HK$51.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$3.66-185.45%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.14 440.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.26 887.14%๐Ÿ‡บ๐Ÿ‡ธ USA